Malattie autoimmuni e vaccinazioni
Tóm tắt
Từ khóa
Tài liệu tham khảo
Witebsky E, Rose NR, Terplan K et al. (1957) Chronic thyroiditis and autoimmunization. JAMA 164:1439–1447
Rose NR, Bona C (1993) Defining criteria for autoimmune diseases (Witebsky’s postulates revisited). Immunol Today 14:426–430
Rose N, Mackay I (eds) (2014) The autoimmune diseases, 5th edn. Elsevier, Amsterdam
Betterle C, Presotto F (2011) Il rischio di malattia conclamata nei soggetti con autoanticorpi organo-specifici. L’endocrinologo 12:134–144
Ahmed SS, Lambert PH (2014) Autoimmune diseases: the role for vaccines. In: Rose N, Mackay I (eds) The autoimmune diseases, 5th edn. Elsevier, Amsterdam, pp 275–282
Olsen NJ, Kovacs WJ (1996) Gonadal steroids and immunity. Endocr Rev 17:369–384
Weiberg K, Parkman R (1995) Age, the thymus, and T lymphocytes. Lancet 332:182–183
Salemi S, D’Amelio R (2010) Could autoimmunity be induced by vaccination? Int Rev Immunol 29:247–269
Cruz-Tapias P, Blank M, Anaya JM, Shoenfeld Y (2012) Infections and vaccines in the etiology of antiphospholipid syndrome. Rheumatology 24:389–393
World Health Organization (2013) Immunization safety surveillance, 2nd edn. WHO Press, Geneva
Coffman RL, Sher A, Seder RA (2010) Vaccine adjuvants: putting innate immunity to work. Immunity 33:492–503
Shoenfeld Y, Aron-Maor A (2000) Vaccination and autoimmunity-“vaccinosis”: a dangerous liaison? J Autoimmun 14:1–10
Schattner A (2005) Consequence or coincidence? The occurrence, pathogenesis and significance of autoimmune manifestations after viral vaccines. Vaccine 23:3876–3886
Zafrir Y, Agmon-Levin N, Paz Z et al. (2012) Autoimmunity following hepatitis B vaccine as part of the spectrum of “Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants” (ASIA): analysis of 93 cases. Lupus 21:146–152
Institute of Medicine of the National Academies (2012) Adverse effects of vaccines. Evidence and causality. National Academies Press, Washington, pp 435–503
De Martino M, Chiappini E, Galli L (2013) Vaccines and autoimmunity. Int J Immunopath Pharmacol 26:283–290
Bonnet MC, Dutta A, Weinberger C, Plotkin SA (2006) Mumps vaccine virus strains and aseptic meningitis. Vaccine 24:7037–7045
Soriano A, Verrecchia E, Marinaro A et al. (2012) Giant cell arteritis and polymyalgia rheumatica after influenza vaccination: report of 10 cases and review of the literature. Lupus 21:153–157
Rizzo C, Bella A, Viboud C et al. (2007) Trends for influenza-related deaths during pandemic and epidemic seasons, Italy, 1969–2001. Emerg Infect Dis 13:694–699
Simonsen L, Spreeuwenberg P, Lustig R et al. (2013) Global mortality estimates for the 2009 influenza pandemic from the GLaMOR project: a modeling study. PLoS Med 10:e1001558
National Institute for Health and Welfare (2010) National Institute for Health and Welfare recommends discontinuation of Pandemrix vaccinations. www.thl.fi/en_US/web/en/pressrelease?id=22930
Nohynek H, Jokinen J, Partinen M et al. (2012) AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS ONE 7:e335–e336
Miller E, Andrews N, Stellitano L et al. (2013) Risk of narcolepsy in children and young people receiving AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine: retrospective analysis. BMJ 346:f794
Dauvilliers Y, Arnulf I, Lecendreux M et al. (2013) Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain 136:2486–2496
Dyer C (2013) UK government is to reconsider claims of children who developed narcolepsy after vaccination. BMJ 347:f5645
Slade BA, Leidel L, Vellozzi C et al. (2009) Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 302:750–757
Bonanni P, Cohet C, Kjaer SK et al. (2010) A summary of the post-licensure surveillance initiatives for GARDASIL/SILGARD. Vaccine 28:4719–4730
Chao C, Klein NP, Velicer CM et al. (2011) Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med 271:193–203
Tomljenovic L, Shaw CA (2012) No autoimmune safety signal after vaccination with quadrivalent HPV vaccine Gardasil? J Intern Med 272:514–515
Shoenfeld Y (2012) HPV Vaccines and autoimmune diseases. J Intern Med. doi: 10.1111/j.1365-2796.02537
Macartney KK, Chiu C, Georgousakis M, Brotherton JM (2013) Safety of human papillomavirus vaccines: a review. Drug Safety 36:393–412
Laribière A, Miremont-Salamé, Reyre H et al. (2005) Surveillance of adverse effects during a vaccination campaign against meningitis C. Eur J Clin Pharmacol 61:907–911
De Wals P, Deceuninck G, Boucher RM, Ouakki M (2008) Risk of Guillain-Barré syndrome following serogroup C meningococcal conjugate vaccine in Quebec. Can Clin Infect Dis 46:e75–e77
Wise RP, Iskander J, Pratt RD et al. (2004) Postlicensure safety surveillance for 7-valent pneumococcal conjugate vaccine. JAMA 292:1702–1710
Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y (2009) Adjuvants and autoimmunity. Lupus 18:1217–1225
Shoenfeld Y, Agmon-Levin N (2011) ASIA-autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 36:4–8
Perricone C, Colafrancesco S, Mazor RD et al. (2013) Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: unveiling the pathogenic, clinical and diagnostic aspects. J Autoimmun 47:1–16
Isai A, Durand J, Le Meur S et al. (2012) Autoimmune disorders after immunization with influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review. Vaccine 30:7123–7129
da-Silveira CM, Salisbury DM, de-Quantos CA (1997) Measles vaccination and Guillain-Barré syndrome. Lancet 349:14–16
D’Souza RM, Campbell-Lloyd S, Isaacs D et al. (2000) Adverse events following immunization associated with the 1998 Australian measles control campaign. Commun Dis Intell 17:27–33
Lasky T, Terraciano GJ, Magder L et al. (1998) The Guillain-Barré syndrome and the 1992–93 and 1993–94 influenza vaccines. N Engl J Med 339:1797–1802
Salmon DA, Proschan M, Forshee R et al. (2013) Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Lancet 381:1461–1468
Galeotti F, Massari M, D’Alessandro R et al. (2013) Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination; ITANG study group. Eur J Epidemiol 28:433–444
Kinnunen E, Junttila O, Haukka J, Hovi T (1998) Nationwide oral poliovirus vaccination campaign and the incidence of Guillain-Barré Syndrome. Am J Epidemiol 147:69–73
Schessl J, Luther B, Kirschner J et al. (2006) Infections and vaccinations preceding childhood Guillain-Barré syndrome: a prospective study. Eur J Pediatr 165:605–612
Blom L, Nyström L, Dahlquist G (1991) The Swedish childhood diabetes study. Vaccinations and infections as risk determinants for diabetes in childhood. Diabetologia 34:176–181
Dahlquist G, Gothefors L (1995) The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. Diabetologia 38:873–874
Dahlquist G, Gothefors L (1996) The cumulative incidence of childhood diabetes mellitus in Sweden unaffected by BCG-vaccination. Diabetologia 39:502
Classen JB (1996) Childhood immunisation and diabetes mellitus. N Z Med J 109:195
Heijbel H, Chen RT, Dahlquist G (1997) Cumulative incidence of childhood-onset IDDM is unaffected by pertussis immunization. Diabetes Care 20:173–175
Graves PM, Barriga KJ, Norris JM et al. (1999) Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care 22:1694–1697
Uno Y, Uchiyama T, Kurosawa M et al. (2012) The combined measles, mumps, and rubella vaccines and the total number of vaccines are not associated with development of autism spectrum disorder: the first case-control study in Asia. Vaccine 30:4292–4298
Wakefield AJ, Murch SH, Anthony A et al. (1998) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 351:637–641
Retraction (2010) Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 375:445
Parker SK, Schwartz B, Todd J, Pickering LK (2004) Thimerosal-containing vaccines and autistic spectrum disorder: a critical review of published original data. Pediatrics 114:793–804
Taylor B, Miller E, Farrington CP et al. (1999) Autism and measles, mumps and rubella vaccine: no epidemiological evidence for a causal association. Lancet 353:2026–2029
DeWilde S, Carey IM, Richards N et al. (2001) Do children who become autistic consult more often after MMR vaccination? Br J Gen Pract 51:226–227
Smeeth L, Cook C, Fombonne E et al. (2004) MMR vaccination and pervasive developmental disorders: a case-control study. Lancet 364:963–969
De Stefano F, Bhasin TK, Thompson WW et al. (2004) Age at first measles-mumps-rubella vaccination in children with autism an school-matched control subjects: a population-based study in metropolitan Atlanta. Pediatrics 113:259–266
De Stefano F, Price CS, Weintraub ES (2013) Increasing exposure to antibody-stimulating proteins and polysaccharides in vaccines is not associated with risk of autism. J Pediatr 163:561–567
Tozzi AE, Bisiacchi P, Tarantino V et al. (2009) Neuropsychological performance 10 years after immunization in infancy with thimerosal-containing vaccines. Pediatrics 123:475–482
Millet A, Decaux O, Perlat A et al. (2009) Systemic lupus erythematosus and vaccination. Eur J Intern Med 20:236–241
Stübgen JP (2014) A review on the association between inflammatory myopathies and vaccination. Autoimmun Rev 13:31–39
Toplak N, Kveder T, Trampus-Bakija A et al. (2008) Autoimmune response following annual influenza vaccination in 92 apparently healthy adults. Autoimmun Rev 8:134–138
Müller-Ladner C, Müller-Ladner U (2013) Vaccination and inflammatory arthritis: overview of current vaccines and recommended uses in rheumatology. Curr Rheumatol Rep 15:330–336
Abu-Shakra M, Zalmanson S, Neumann L et al. (2000) Influenza virus vaccination of patients with systemic lupus erythematosus: effects on disease activity. J Rheumatol 2:1681–1685
Shoenfeld Y (2009) Influenza vaccine and autoimmunity. IMAJ 11:183–184
Perdan-Pirkmajer K, Thallinger GG, Snoj N et al. (2012) Autoimmune response following influenza vaccination in patients with autoimmune inflammatory rheumatic disease. Lupus 21:175–183
Bijl M, Agmon-Levin N, Dayer JM et al. (2012) Vaccination of patients with auto-immune inflammatory rheumatic diseases requires careful benefit-risk assessment. Autoimmun Rev 11:572–576
Benchimol EI, Hawken S, Kwong JC, Wilson K (2013) Safety and utilization of influenza immunization in children with inflammatory bowel disease. Pediatrics 131:e1811–e1820
Salemi S, D’Amelio R (2010) Are anti-infectious vaccinations safe and effective in patients with autoimmunity? Int Rev Immunol 29:270–314
Jutel M, Akdis CA (2011) Immunological mechanisms of allergen-specific immunotherapy. Allergy 66:725–732
Linneberg A, Jacobsen RK, Jespersen L, Abildstrom SZ (2012) Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune diseases, ischemic heart disease, and mortality. J Allergy Clin Immunol 129:413–419
Poland AG, Jacobson RM (2012) The clinician’s guide to the anti-vaccinationist’ galaxy. Hum Immunol 73:859–866
AIFA (2012) Rapporto sulla sorveglianza postmarketing dei vaccini in Italia, pp 1–101. http://www.agenziafarmaco.gov.it